Prof. PeptideProf. Peptide

Crystagen: Benefits, Dosage and Side Effects in 2026

Crystagen is a short synthetic peptide from the Khavinson bioregulator series, sold for immune support1. No human study of it has been published; its one reported effect, activating B cells in the aging spleen, comes from research outside people1. It is not approved for use in people.

Other names: immune bioregulator peptide. Related: Thymogen and Thymalin.

  • Gut Health & Immunity
  • Research-Grade

Last updated November 17, 2026 by the Prof. Peptide editorial team

What is Crystagen?

Crystagen is a synthetic tripeptide, Glu-Asp-Pro (EDP), from the bioregulator series developed by Vladimir Khavinson's group, which lists it as an immunoprotector3. It is not the prostate peptide Prostomax (KEDP), which differs by one amino acid3. It has never been tested in a clinical trial, and it is not approved for use in people.

What it is
A synthetic tripeptide, Glu-Asp-Pro (EDP)3.
How it's taken
No human route has been studied.
Half-life
No published half-life figure.
How it's dosed
No label, trial or clinic sets a dose.
Research status
Not approved for use in people.

Where to buy Crystagen?

Crystagen has no prescription product anywhere. Research-grade Crystagen is sold by specialty peptide vendors for laboratory use only, with no label behind it. The vendors listed here sell it, each with Prof. Peptide's code. Each vendor name links to its Prof. Peptide page, with the vendor's catalog, testing and shipping details.

Ion Peptide

✓ Lab & COAs Verified🇺🇸 US
15% off
Ion Peptide logo

Fusion Peptide

✓ Lab & COAs Verified🇺🇸 US
15% off
Fusion Peptide logo

Ion Peptide: Bundle prices up to 45% off, plus 15% with Prof. Peptide’s code, no end date given · checked Nov 17. All current deals

See all 225 vendors

How much does Crystagen cost?

Crystagen costs from $1.40 to $2.51 per mg after Prof. Peptide's code, across 4 listings from 4 vendors, with prices as of November 16, 2026; the median listing is $1.94 per mg. Listings are shown lowest first. The price on top is after the PROFPEPTIDE discount code, and the crossed-out price is the vendor's regular price.

20 mg$1.40/mg$1.65/mgSale$28.04$32.99
NextGenPepsOut of stock
20 mg$1.94/mg$2.15/mgSale$38.70$43.00
LA Peptidesprice read Nov 14
20 mg$1.95/mg$3.00/mg$38.99$59.99
Ion PeptideOut of stock
20 mg$2.51/mg$2.95/mg$50.15$59.00

Prices as of November 16, 2026; a listing read earlier shows its own date

Price trend, vendors' own listed price before any code (median per mg): $2.95 on September 28, 2026 → $2.75 on November 16, 2026. These medians come from the nightly price file, which held 1 listing on the first date and 5 listings on the last, including listings the table above leaves out (vendors excluded, retired or not re-read recently); more vendors were added over the period.

What are Crystagen's uses and reported benefits?

Crystagen is sold for immune support, and its developers' family table lists it as an immunoprotector3, but no benefit in people has been shown. Its one reported effect, activating antibody-making B cells in the aging spleen without renewing spleen cells, comes from research outside people1.

How does Crystagen work?

Crystagen's proposed mechanism is the one its developers give for short peptides generally: entering cells and binding DNA to change gene expression2. In the aging spleen it activated B cells, the immune cells that make antibodies, in research outside people1. None of this has been measured in people.

How is Crystagen dosed?

No label, trial or clinic sets a Crystagen dose. No clinic was found publishing a dose after searching the 8 largest US peptide clinics and Prof. Peptide's registry of clinics, which holds no Crystagen entry, and no compounding pharmacy page naming it was found. The doses used in research outside people do not translate to people.

Need to calculate a dose?

Use the Prof. Peptide dosage calculator for accurate reconstitution and dosing math.

Open Calculator

How is Crystagen taken?

Crystagen has no studied route in people, so no route is described here. No approved label sets out a route, and research-grade Crystagen is sold for laboratory use only, labeled by its vendors as not for human consumption. The peptide dosage calculator works out the water and syringe units for a research-grade vial; it does not set a dose.

What are the side effects of Crystagen?

Crystagen's side effects in people are unknown: no human safety data and no adverse-event report have been published. Its one reported effect, activating B cells in the aging spleen, comes from research outside people1, which does not show safety in people, and research-grade Crystagen is sold for laboratory use only.

No clinic was found listing side effects or cautions for Crystagen after searching the 8 largest US peptide clinics and Prof. Peptide's registry of clinics.

Is Crystagen legal?

Crystagen is not approved for use in people anywhere, and no clinic states a prescription route for it; research-grade vials are sold for laboratory use only. In sport, the 2026 WADA Prohibited List does not name it, and its S0 class prohibits unapproved substances at all times.

Legal status

  • FDA: it is not on the bulk-substance safety-risk page6, in none of the three 503A nomination categories4, and not on the agenda of FDA's July 2026 advisory committee5.
  • Sport: not named on the 2026 WADA Prohibited List, whose S0 class prohibits at all times any substance with no current approval for human therapeutic use.
  • Research-grade vials: sold for laboratory use only, not for human use; a research-use label does not make a vial an approved or prescribed product.

No clinic was found describing its status after searching the 8 largest US peptide clinics and Prof. Peptide's registry of clinics.

What do human studies show about Crystagen?

Crystagen has no published human study: no trial, case series or pharmacokinetic study in people. Its one reported effect comes from research outside people by the group that developed it1, and its proposed mechanism from that group's review2. No human data exist on its dose or safety.

In a Prof. Peptide count of Europe PMC on November 5, 2026, one record names Crystagen, the aging-spleen study, and none is a trial1.

Evidence levelLevel 2 of 4
Prof. Peptide's evidence level records the highest study design used, not whether results were good1.

What does animal and lab research show about Crystagen?

Crystagen's one reported effect comes from work on the aging spleen: alongside the related peptides Vilon, Timogen and R-1, it activated B cells of the immune system, though unlike Timogen it did not renew spleen cells1. Animal and lab results do not show that the same happens in people.

Crystagen FAQ

Has Crystagen been studied in people?

Crystagen has never been tested in a clinical trial: Europe PMC lists one paper naming it1. Its one reported effect, activating antibody-making B cells in the aging spleen, comes from research outside people by the group that developed it1. No human data exist on its dose, route or safety. See What do human studies show about Crystagen?

Where can I buy Crystagen?

Crystagen is not approved for use in people, so no prescription product exists. Research-grade material is sold by vendors for laboratory use only. Where to buy Crystagen? lists vendors with Prof. Peptide's code, and How much does Crystagen cost? compares prices. The verified discount codes page lists every vendor with a code.

References

Show all references

  1. Molecular aspects of immunoprotective activity of peptides in spleen during the ageing processAnimal studyChervyakova NA, Linkova NS, Chalisova NI, et al. Adv Gerontol. 2014. In Russian; abstract read November 3, 2026.PubMed 28976144 →
  2. Peptide Regulation of Gene Expression: A Systematic ReviewReviewKhavinson VK, Popovich IG, Linkova NS, et al. Molecules. 2021. Abstract read November 3, 2026.PubMed 34834147 →DOI →
  3. Transport of Biologically Active Ultrashort Peptides Using POT and LAT CarriersReviewKhavinson V, Linkova N, Kozhevnikova E, et al. Int J Mol Sci. 2022. Full text read November 5, 2026.Key finding: Table 2: "Crystagen (EDP) … Immunoprotector", citing US Patent 8,057,810 (2011), a peptide substance with an immunogeroprotective effect; "Prostomax (KEDP) … Regulation of prostatic functions", citing EP1353939.PubMed 35887081 →DOI →
  4. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (Categories 1, 2 and 3)RegulatorU.S. Food and Drug Administration. Updated May 14, 2026; read November 5, 2026. Crystagen appears in none of the three categories.fda.gov →
  5. Pharmacy Compounding Advisory Committee, July 23–24, 2026: final agendaRegulatorU.S. Food and Drug Administration. Read November 5, 2026. Seven substances; Crystagen is not among them.fda.gov →
  6. Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2)RegulatorU.S. Food and Drug Administration. Content current as of April 22, 2026; read November 5, 2026. Crystagen is not listed.fda.gov →

Affiliate disclosure: Prof. Peptide earns a commission on purchases and sign-ups made through its links and codes, at no extra cost to the buyer. Commissions never decide which vendors are listed, how they are ranked or verified, or what Prof. Peptide concludes.

Have a question about Crystagen? Send us an email

Checked and updated